Target intelligence / Profile preview

CEA cell adhesion molecule pseudogene 3 (CEACAMP3)

Target: CEACAMP3
Molecular classification: Other

Overview

CEA cell adhesion molecule pseudogene 3 (CEACAMP3) is annotated as a pseudogene in the Homo sapiens genome. It does not encode a functional protein and lacks characterized biological activity, disease associations, or therapeutic relevance. Pseudogenes typically result from gene duplication or retrotransposition but have lost protein-coding potential through mutation or truncation. CEACAMP3 (pseudogene) is distinct from CEACAM3, a functional cell surface receptor involved in neutrophil-mediated phagocytosis; therefore, CEACAMP3 is not a therapeutic target and should not be confused with CEACAM3[7].

Other names: CEACAM24PCGM10

Beyond the preview

Go deeper on CEA cell adhesion molecule pseudogene 3 (CEACAMP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CEA cell adhesion molecule pseudogene 3 (CEACAMP3).

Explore the full profile